| Fibroblast growth factor-23 and cardiovascular events in CKD JJ Scialla, H Xie, M Rahman, AH Anderson, T Isakova, A Ojo, X Zhang, ... Journal of the American Society of Nephrology 25 (2), 349-360, 2014 | 543 | 2014 |
| Fibroblast growth factor 23 is not associated with and does not induce arterial calcification JJ Scialla, WL Lau, MP Reilly, T Isakova, HY Yang, MH Crouthamel, ... Kidney international 83 (6), 1159-1168, 2013 | 429 | 2013 |
| Dialysis initiation, modality choice, access, and prescription: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference CT Chan, PJ Blankestijn, LM Dember, M Gallieni, DCH Harris, CE Lok, ... Kidney international 96 (1), 37-47, 2019 | 325 | 2019 |
| An overview of regular dialysis treatment in Japan (as of 31 December 2013) I Masakane, S Nakai, S Ogata, N Kimata, N Hanafusa, T Hamano, ... Therapeutic Apheresis and Dialysis 19 (6), 540-574, 2015 | 315 | 2015 |
| Fetuin-mineral complex reflects extraosseous calcification stress in CKD T Hamano, I Matsui, S Mikami, K Tomida, N Fujii, E Imai, H Rakugi, ... Journal of the American Society of Nephrology 21 (11), 1998-2007, 2010 | 249 | 2010 |
| The CXCL12 (SDF-1)/CXCR4 axis is essential for the development of renal vasculature Y Takabatake, T Sugiyama, H Kohara, T Matsusaka, H Kurihara, PA Koni, ... Journal of the American Society of Nephrology 20 (8), 1714-1723, 2009 | 189 | 2009 |
| Overview of regular dialysis treatment in Japan (as of 31 December 2008) S Nakai, K Suzuki, I Masakane, A Wada, N Itami, S Ogata, N Kimata, ... Therapeutic Apheresis and Dialysis 14 (6), 505-540, 2010 | 177 | 2010 |
| Serum phosphate and calcium should be primarily and consistently controlled in prevalent hemodialysis patients M Taniguchi, M Fukagawa, N Fujii, T Hamano, T Shoji, K Yokoyama, ... Therapeutic Apheresis and Dialysis 17 (2), 221-228, 2013 | 161 | 2013 |
| An Overview of Regular Dialysis Treatment in J apan (as of 31 D ecember 2012) S Nakai, N Hanafusa, I Masakane, M Taniguchi, T Hamano, T Shoji, ... Therapeutic Apheresis and Dialysis 18 (6), 535-602, 2014 | 160 | 2014 |
| An overview of regular dialysis treatment in Japan (as of 31 December 2010) S Nakai, K Iseki, N Itami, S Ogata, JJ Kazama, N Kimata, T Shigematsu, ... Therapeutic Apheresis and Dialysis 16 (6), 483-521, 2012 | 148 | 2012 |
| Fully phosphorylated fetuin-A forms a mineral complex in the serum of rats with adenine-induced renal failure I Matsui, T Hamano, S Mikami, N Fujii, Y Takabatake, Y Nagasawa, ... Kidney international 75 (9), 915-928, 2009 | 148 | 2009 |
| Annual dialysis data report 2015, JSDT renal data registry I Masakane, M Taniguchi, S Nakai, K Tsuchida, S Goto, A Wada, S Ogata, ... Renal Replacement Therapy 4 (1), 1-99, 2018 | 144 | 2018 |
| Annual dialysis data report for 2018, JSDT Renal Data Registry: survey methods, facility data, incidence, prevalence, and mortality K Nitta, S Goto, I Masakane, N Hanafusa, M Taniguchi, T Hasegawa, ... Renal Replacement Therapy 6, 1-18, 2020 | 143 | 2020 |
| Combined use of vitamin D status and FGF23 for risk stratification of renal outcome C Nakano, T Hamano, N Fujii, I Matsui, K Tomida, S Mikami, K Inoue, ... Clinical Journal of the American Society of Nephrology 7 (5), 810-819, 2012 | 143 | 2012 |
| Controversies in optimal anemia management: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference JL Babitt, MF Eisenga, VH Haase, AV Kshirsagar, A Levin, F Locatelli, ... Kidney international 99 (6), 1280-1295, 2021 | 130 | 2021 |
| Overview of Regular Dialysis Treatment in J apan (as of 31 D ecember 2011) S Nakai, Y Watanabe, I Masakane, A Wada, T Shoji, T Hasegawa, ... Therapeutic Apheresis and Dialysis 17 (6), 567-611, 2013 | 130 | 2013 |
| Activation of the signal transducer and activator of transcription signaling pathway in renal proximal tubular cells by albumin H Nakajima, M Takenaka, JY Kaimori, T Hamano, H Iwatani, T Sugaya, ... Journal of the American Society of Nephrology 15 (2), 276-285, 2004 | 130 | 2004 |
| Cigarette smoking and progression of IgA nephropathy R Yamamoto, Y Nagasawa, T Shoji, H Iwatani, T Hamano, N Kawada, ... American Journal of Kidney Diseases 56 (2), 313-324, 2010 | 129 | 2010 |
| A randomized trial of magnesium oxide and oral carbon adsorbent for coronary artery calcification in predialysis CKD Y Sakaguchi, T Hamano, Y Obi, C Monden, T Oka, S Yamaguchi, I Matsui, ... Journal of the American Society of Nephrology 30 (6), 1073-1085, 2019 | 120 | 2019 |
| Urine neutrophil gelatinase–associated lipocalin levels do not improve risk prediction of progressive chronic kidney disease KD Liu, W Yang, AH Anderson, HI Feldman, S Demirjian, T Hamano, J He, ... Kidney international 83 (5), 909-914, 2013 | 113 | 2013 |
Yoshitsugu ObiUniversity of Mississippi Medical CenterVerified email at umc.edu
